Knoa Pharma Overview
- Year Founded
-
1892
- Status
-
Private
- Employees
-
922
- Latest Deal Type
-
Bankr. Admin/Reorg
- Financing Rounds
-
2
- Investments
-
9
Knoa Pharma General Information
Description
Developer of medications and consumer health products intended to meet the needs of healthcare professionals, patients, consumers, and caregivers. The company is primarily into the development of formulations containing opioid agonists such as oxycodone, morphine, buprenorphine, and hydrocodone for pain relief purposes, along with laxatives, antiseptics, dietary supplements, and an injectable drug for opioid overdose.
Contact Information
Website
www.knoapharma.comCorporate Office
- One Stamford Forum
- 201 Tresser Boulevard
- Stamford, CT 06901-3431
- United States
Corporate Office
- One Stamford Forum
- 201 Tresser Boulevard
- Stamford, CT 06901-3431
- United States
Knoa Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Knoa Pharma Comparisons
Industry
Financing
Details
Knoa Pharma Competitors (55)
One of Knoa Pharma’s 55 competitors is Novartis, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland | ||||
| Shionogi | Corporation | Osaka, Japan | ||||
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ | ||||
| Hoechst Pakistan | Corporate Backed or Acquired | Karachi, Pakistan | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India |
Knoa Pharma Patents
Knoa Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024402318-A1 | Autoinjector for opioid overdose rescue | Pending | 21-Dec-2023 | ||
| EP-4827961-A1 | Autoinjector for opioid overdose rescue | Pending | 21-Dec-2023 | ||
| JP-2026533031-A | Snobinop for use in the treatment of alcohol use disorder | Pending | 19-Oct-2023 | ||
| AU-2024364388-A1 | Sunobinop for use in method of treating alcohol use disorder | Pending | 19-Oct-2023 | ||
| EP-4794697-A1 | Sunobinop for use in method of treating alcohol use disorder | Pending | 19-Oct-2023 | A61K31/498 |
Knoa Pharma Signals
Knoa Pharma Investments & Acquisitions (9)
Knoa Pharma’s most recent deal was a Later Stage VC with Frenelle Pharma for . The deal was made on 28-Aug-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Frenelle Pharma | 28-Aug-2018 | Later Stage VC | Drug Discovery | ||
| CognifiSense | 02-Feb-2018 | Grant | Therapeutic Devices | ||
| VM Pharma (TrkA Program) | 08-Sep-2015 | Corporate Asset Purchase | Buildings and Property | ||
| Kolltan Pharmaceuticals | 17-Mar-2014 | Later Stage VC | Drug Discovery | ||
| NASCSA | 23-Oct-2012 | Grant | Media and Information Services (B2B) |
Knoa Pharma Exits (4)
Knoa Pharma’s most recent exit was on 17-Mar-2014 from Kolltan Pharmaceuticals. The exit was categorized as with 12 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Kolltan Pharmaceuticals | 17-Mar-2014 | Completed |
|
||
| Infinity Pharmaceuticals | 01-Jul-2012 | Completed |
|
||
| Kolltan Pharmaceuticals | 18-Aug-2009 | Completed |
|
||
| Optherion | 09-Oct-2007 | Early Stage VC | Completed |
|
Knoa Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CoCensys | Irvine, CA | 1989 |
Knoa Pharma FAQs
-
When was Knoa Pharma founded?
Knoa Pharma was founded in 1892.
-
Where is Knoa Pharma headquartered?
Knoa Pharma is headquartered in Stamford, CT.
-
What is the size of Knoa Pharma?
Knoa Pharma has 922 total employees.
-
What industry is Knoa Pharma in?
Knoa Pharma’s primary industry is Drug Discovery.
-
Is Knoa Pharma a private or public company?
Knoa Pharma is a Private company.
-
What is Knoa Pharma’s current revenue?
The current revenue for Knoa Pharma is .
-
Who are Knoa Pharma’s competitors?
Novartis, Shionogi, Johnson&Johnson Innovative Medicine, Hoechst Pakistan, and Evonile Pharma are some of the 55 competitors of Knoa Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process